Natural Capsules Limited has informed the Exchange about Investor Presentation
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Capsules Limited shared its Q3FY26 investor presentation showing a sharp deterioration in financials. Revenue fell 18% quarter-on-quarter and 14% year-on-year to ₹37.75 crore, while EBITDA turned negative at ₹(2.33) crore with margins sliding to -6.16% (a 423 bps drop QoQ). Profit after tax was ₹(7.12) crore versus a marginal profit a year ago, and EPS was negative at ₹(6.88). Management attributed the weakness to a temporary regulatory shutdown of the Puducherry capsule unit (now resolved) and slower-than-expected commercial scale-up of the fermentation block at its API subsidiary. On a positive note, US trade tariffs on HPMC capsules have eased, and the company is in advanced discussions with partners to use the fermentation block on a contract basis. Management expects a meaningful improvement in Q4FY26 as both plants run normally and delayed shipments are dispatched.
Shareholders should expect a negative initial reaction given the swing to losses and steep margin compression, though management's recovery narrative for Q4FY26 and easing of US tariff headwinds provide some support. Investors should watch Q4FY26 dispatches from Puducherry and progress on the fermentation block partnership as key catalysts.